Rituximab/Temozolomide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rituximab/Temozolomide, covering 2026-04-27 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) [Phase 3]